NBE THERAPEUTICS AG has a total of 66 patent applications. It increased the IP activity by 280.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are L BASE CO LTD, SEAGEN INC and ONCOQUEST INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | Australia | 7 | |
#5 | Canada | 5 | |
#6 | Singapore | 5 | |
#7 | Brazil | 4 | |
#8 | Israel | 4 | |
#9 | China | 3 | |
#10 | Republic of Korea | 2 | |
#11 | South Africa | 2 | |
#12 | Hong Kong | 1 | |
#13 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Fermentation | |
#5 | Enzymes | |
#6 | Measuring microorganism processes | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Grawunder Ulf | 56 |
#2 | Beerli Roger | 36 |
#3 | Waldmeier Lorenz | 22 |
#4 | Beerli Roger Renzo | 20 |
#5 | Gebleux Remy | 12 |
#6 | Ulf Grawunder | 9 |
#7 | Roger Renzo Beerli | 8 |
#8 | Hellmann Ina | 7 |
#9 | Pretto Francesca | 4 |
#10 | Rader Christoph | 4 |
Publication | Filing date | Title |
---|---|---|
EP3647419A1 | Sortase f and its use in methods for conjugation | |
EP3636284A1 | Binding protein-toxin conjugates comprising anthracyclines, and use thereof in immune-oncological applications | |
CA3071212A1 | Anthracycline-based antibody drug conjugates having high in vivo tolerability | |
EP3655435A1 | Multispecific antibody product that binds to different ror1 epitopes | |
WO2019016392A1 | Human antibodies binding to ror2 | |
US2019112385A1 | Anti-mesothelin antibodies | |
KR20180069067A | Anti-ROR1 antibody | |
EP3256166A1 | Maytansine-drug conjugates of her- 2 specific binding proteins generated by site specific sortase-enzyme mediated conjugation | |
CN107750169A | Associated proteins drug conjugate comprising anthracycline derivative |